| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | 10x Genomics Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬 Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team … Type: | 0 | 0 | 0 | 2,033 |
 |  23andMe 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers … Type: | 20 | 3 | 4 | 888 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 4 |
 |  3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 0 | 0 | 0 | 53 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an abitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 13 |
 | 3-D Matrix EMEA 3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical Devices, Medical Technology, Peptide Technology, and haemostat Type: | 1 | 0 | 0 | 49 |
 | 3M Health Care At 3M Health Care, science is our pursuit. Improving lives is our purpose. We believe nothing is more important than good health. It’s this belief that inspires us to develop reliable, quality products and solutions for the global health care industry. Whether you’re connecting with patients directly, developing biopharmaceutical solutions or designing a medical device, the work you do every day is improving lives. Medical products and solutions, Dental and orthodontic supplies, Health information solutions, Food safety, and Drug delivery solutions Type: | 5 | 1 | 4 | 18 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 2 | 0 | 1 | 230 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 1 | 1 | 0 | 11 |
 | 4P-Pharma 4P-Pharma is a clinical stage biotech company founded in Lille in 2014. We focus on untreated serious diseases with high unmet medical needs, aiming to rapidly deliver effective, regenerated, first-in-class therapies. The company has developed a proprietary development engine to address the main pain points of traditional drug development: time, costs, and predictability to deliver optimized risk adjusted returns. We leverage assets with a short time to market, strong IP position, and regulatory opportunities (emergency use or conditional marketing authorizations) in blue-ocean markets. Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and Development, Drug Development, Preclinical development, Clinical development, … Type: | 5 | 2 | 3 | 30 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: | 1 | 1 | 0 | 20 |
 |  9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture Type: | 0 | 0 | 0 | 2 |
 | A-Alpha Bio The protein-protein interaction company A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of … Type: | 4 | 0 | 4 | 53 |
 | AATec Medical Unlocking the therapeutic potential of AAT AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections. Type: | 0 | 0 | 0 | 7 |
 | Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: | 8 | 4 | 6 | 48 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 10 |
 | AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: | 9 | 1 | 2 | 551 |
 | ABC transfer Ultraclean Sterile Transfer Solutions For The Global Pharmaceutical Industry ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the pharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria resolving customers’ challenges worldwide. Led by an executive team of pharma transfer solution experts with decades … Type: | 0 | 0 | 0 | 11 |
 | ABEC engineered solutions and services for biotech manufacturing ABEC engineered solutions and services for biotech manufacturing Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key … Type: | 1 | 0 | 1 | 582 |
 |  AbiliLife Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. … Type: | 0 | 0 | 0 | 1 |
 | AbilyCare The digital solution to measure one's walk and balance Based on French research, Abilycare was developed by and for practitioners. AbilyCare is a solution that measures walk and balance in order to prevent frailty risks at any moment of our life. It's a medical device (certification in progress), easy and fast to use in order to : - detect early signs of frailty - develop preventive actions to initiate the process of reversibility - monitor the patient's state over time and measure the benefit of a rehabilitation or prevention program Type: | 12 | 4 | 7 | 7 |
 | Abingdon Health plc Improving life by making rapid results accessible to all. Lateral flow test development, manufacture & commercialisation We are lateral flow CDMO experts based in the UK supporting global customers bring their assays to market, from proof of concept, through optimisation and scale up to routine manufacture, along with full-service regulatory consultancy support. Get in touch: email info@abingdonhealth.com today. We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the … Type: | 5 | 0 | 3 | 73 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is a potential first-line advanced therapy for moderately to severely active ulcerative colitis designed to enhance the expression of a single micro-RNA, miR-124, which is a natural regulator of the … Type: | 8 | 5 | 4 | 76 |
 | ABL GMP PURE-PLAY VIRAL VECTOR CDMO. From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< … Type: | 5 | 5 | 2 | 515 |
 | ABL Diagnostics S.A [Automatic translation follows] Improving Disease Management Founded in 2015, ABL DIAGNOSTICS designs, develops, manufactures, markets and supports in France and internationally, directly or via a network of exclusive distributors in 45 countries, molecular biology diagnostic tests for detection (UltraGene®) and genotyping by DNA sequencing (DeepChek®), for infectious diseases. These are the result of proprietary know-how acquired over the years and scientific collaborations with renowned teams and dedicated technical protocols. ABL DIAGNOSTICS has particularly developed high-tech genotyping medical devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and also for the genotyping of SARS-CoV-2 (Covid-19), as well as other … Type: | 1 | 1 | 0 | 22 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 15 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make … Type: | 11 | 1 | 11 | 42 |
 | Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: | 7 | 0 | 8 | 184 |
 | AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … Type: | 2 | 1 | 0 | 104 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: | 2 | 2 | 0 | 2 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 446 |
 | Acceleron Pharma Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Type: | 4 | 1 | 2 | 75 |
 | Access to Medicine Foundation Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and … Type: | 6 | 3 | 3 | 52 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 19 |
 | Acime Frame Mindful Design ACIME FRAME has been designing and manufacturing mobile medical equipment for patient transport and care since 1990. Our comprehensive range of products includes stretchers, transfer chairs, treatment chairs, ambulatory surgery chairs, examination couches, and screens. We strive to provide patients and caregivers with the most user-friendly medical devices: comfort, durability, innovation, design, and adaptability are at the core of our mission to improve the recovery process. We work with healthcare providers to identify and analyse their needs and thus provide them with the best solutions to make their lives easier. ambulatory care, patient transfer, emergencies, dialysis, day hospital, … Type: | 3 | 3 | 1 | 75 |
 | AC Immune We shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical … Type: | 4 | 1 | 2 | 171 |
 | ACM Global Laboratories Delivering state-of-the-art central lab services across the globe ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400 Central Laboratory Testing for Global Clinical Trials, Central Laboratory Services, Clinical Trials Testing, … Type: | 0 | 0 | 0 | 430 |
 | ACM Pharma [Automatic translation follows] Your partner specializing in contamination control Microbiological analysis laboratory for health products. Located in the heart of the Center Val de Loire region close to major pharmaceutical and cosmetics centers, the microbiology laboratory, run by specialized pharmacists and scientists, brings its know-how and experience of more than 10 years to the service of the pharmaceutical industries , manufacturers of medical and cosmetic devices. Analyzes carried out in the laboratory: Microbial contamination, endotoxins, sterility testing, bacterial identification, antibiotics, water analysis, challenge tests, testing of antiseptics and disinfectants. Microbiology laboratory, Monotoring of clean rooms, Challenge-test, Bacterial identification, Endotoxin, Antibiotic, … Type: | 0 | 0 | 0 | 54 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 0 | 0 | 0 | 5 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 37 |
 | action medeor e.V. Die Notapotheke der Welt. Founded 1964, the charitable, non-governmental organization action medeor e.V. today is the largest medical aid organization in Europe. action medeor supports around 10.000 healthcare facilities in 140 countries all over the world. Medical facilities receive drugs as well as medical equipment and supplies either at cost price or as donations. Our aid is supplied in co-operation with different church and secular organizations, religious communities, private initiatives and healthcare centers abroad. Based on many years’ experience, action medeor has built up a comprehensive network of facilities in the healthcare sector. Emergency and disaster relief In cases of … Type: | 0 | 0 | 0 | 65 |
 | Action Medical Research We fight for children's lives We fight for answers. Answers that can lead to cures, treatment and medical breakthroughs. Action Medical Research is a UK-wide charity funding vital research to help sick and disabled babies and children. We fight for answers that can lead to cures, treatments and medical breakthroughs for some of the toughest fights our children face. Since we began in 1952, we have been funding medical breakthroughs and almost everyone has been touched in some way by our groundbreaking work - like the first polio vaccines in the UK, ultrasound in pregnancy and the rubella vaccine. Today, … Type: | 3 | 0 | 1 | 79 |
 | Acurable We create accurate and user friendly wearable medical devices intended to be used by patients at home Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most … Type: | 3 | 0 | 3 | 31 |
 | AdalbaPro by Ÿnsect smart insect nutrition Ynsect's high-tech vertical farm and processing facility in the Netherlands produces innovative and sustainable ingredients for the food industry derived from insects under the brand name AdalbaPro. Our functional ingredients contain highly digestible proteins along with essential nutritional building blocks like vitamins, minerals, fiber and healthy fats. In our controlled and highly scalable vertical farm, Ynsect reduces your global footprint in the most effective way. High quality protein powder, Edible oils, Sustainable food ingredients, sustainable food, sustainable feed, and protein manufacturing Type: | 4 | 2 | 1 | 10 |
 | Adan Medical Innovation Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a … Type: | 0 | 0 | 0 | 8 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 0 | 0 | 0 | 42 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team … Type: | 1 | 0 | 1 | 306 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 2 | 0 | 2 | 28 |
 | ADDIDREAM ADDIDREAM is a french company dedicated to the medical additive manufacturing. Thanks to a 550 m2 production area of different medical adapted 3D printing technology, we offer innovate solutions for the healthcare industry. Our services include computing aided design (CAO), different types of biocompatible materials 3D printing, and post-treatment processes. Type: | 5 | 5 | 0 | 10 |
 | ADDvise Group AB (publ) Leading supplier of equipment to healthcare and research facilities ADDvise is a leading supplier of equipment to healthcare and research facilities. ADDvise Group AB (publ) is an expanding group that offers total solutions in products and services to healthcare and research facilities through its subsidiaries. We develop and nurtures long-term relationships by offering leading edge competence in our two business units Lab and Healthcare. Our subsidiaries are divided equal into the business fields. Lab creates modern research facilities by providing laboratory furnishings, safety ventilation, climate rooms, clean rooms and laboratory apparatus to e.g. the pharmaceuticals industry and life science research. … Type: | 0 | 0 | 0 | 27 |
 | Ademtech [Automatic translation follows] Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), very magnetic (iron oxide content>70%), calibrated from 100 to 500 nm (+ /- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, viruses) … Type: | 0 | 0 | 0 | 28 |
 | ADEXSOL Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your … Type: | 4 | 0 | 2 | 2 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 3 | 2 | 3 | 116 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 9 | 3 | 6 | 64 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | ADOCIA "Innovative medicine for everyone, everywhere" "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, … Type: | 4 | 2 | 2 | 86 |
 | Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: | 0 | 0 | 0 | 3 |
 | Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: | 4 | 1 | 3 | 21 |
 | Advanced Instruments, LLC Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for … Type: | 2 | 0 | 1 | 469 |
 | ADVANZ PHARMA Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more … Type: | 1 | 0 | 1 | 630 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 141 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 26 |
 | AELIX Therapeutics Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen. Type: | 2 | 1 | 1 | 6 |
 | Aenitis Technologies Acoustic Cell Processing Solution Aenitis develops and promotes devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focuses on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation. Sorting, acoustophoresis, medical devices, cells, and Bioproduction Type: | 19 | 3 | 17 | 15 |
 | Aeras Aeras is a non-profit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Netherlands’ Ministry of Foreign Affairs and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. tuberculosis, vaccines, clinical trials, vaccine manufacturing, and HIV Type: | 1 | 0 | 1 | 63 |
 | Aerogabs Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please … Type: | 0 | 0 | 0 | 1 |
 | Aerogen We're devoted to improving the lives of vulnerable patients worldwide through superior aerosol drug delivery. *Medtech Company of the Year 2020/2021* Aerogen improves the lives of vulnerable patients worldwide through superior aerosol drug delivery – ultimately transforming respiratory care. Dedicated to scientific excellence, Aerogen innovates based on what’s best for the patient and care team and is focused on: - Bringing peace of mind to patients and loved ones by safely and rapidly delivering more medication to the lungs, increasing speed of recovery. - Helping care providers more effectively treat patients, while also empowering them to focus on strategic tasks … Type: | 0 | 0 | 0 | 520 |
 | AESEG [Automatic translation follows] We are the association of the pharmaceutical industry of generic medicines in Spain. AESEG is the association of the pharmaceutical industry of generic medicines in Spain and the qualified business interlocutor in this matter. All pharmaceutical specialty laboratories, pharmaceutical raw material and active ingredient manufacturing companies, or technological development companies whose main activity is carried out in the field of generics within the national territory can be members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization to promote the knowledge and use of generic medicines, creating a true generic … Type: | 0 | 0 | 0 | 11 |
 | AESGP Empowering Self-Care in Europe Established in 1964, the Association of the European Self-Care Industry (AESGP) represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices (an area also referred to as consumer healthcare products). Our mission is to advance responsible self-care, enabling citizens to take better care of their health needs, and to contribute to the sustainability of European healthcare systems. OTC, Substance based MD, Non-prescription medicines, Pharmaceutical, Self-care, and Food supplement Type: | 5 | 0 | 5 | 21 |
 | Aesyra SA Aesyra SA is a spin-off of EPFL created in November 2017 in close collaboration with medical experts from the Clinique Universitaire de Médecine Dentaire de Genève (CUMD). Aesyra’s mission is to develop, manufacture and commercialize a medical device able to accurately monitor the jaw activity of the patient during sleep and provide an active bio-feedback to reduce teeth grinding without waking-up the patient. Type: | 0 | 0 | 0 | 9 |
 | Aether Biomedical Making bionics accessible Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design. A culture focused on building the next generation of bionic devices, utilizing cutting-edge biosignal processing and software integration. After an expansion in Europe and Asia, we are now launching Zeus to the U.S market, with our U.S. headquarters in Chicago, IL. We have developed the Zeus hand, which is the strongest multi-articulating myoelectric hand in the world, providing 30-40% more grip force (152 Newtons) than existing market options! Apart from being the strongest hand, Zeus is highly robust as well. … Type: | 1 | 0 | 1 | 42 |
 | AFAR [Automatic translation follows] Continuing education serving health professionals since 1980 Since 1980, Afar has been serving the training of professionals in public and private health establishments, social and medico-social establishments, local authorities and businesses. Today recognized as one of the main players in training in these sectors, Afar continues its commitment to professionals by offering in particular an offer of expertise in the fields of management, health and safety at work, mental health, disability and mediation. Meeting the objectives of national and regional health programs, our training actions and CPD programs welcome more than 5,600 trainees per year, from more … Type: | 3 | 1 | 3 | 103 |
 | AFFICHEM [Automatic translation follows] Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: | 0 | 0 | 0 | 1 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 3 | 3 | 1 | 36 |
 | AFFiRiS AG Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you. We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and … Type: | 0 | 0 | 0 | 5 |
 | AFFIRMA BIOTECH SL Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation. Type: | 0 | 0 | 0 | 5 |
 | Affluent Medical [Automatic translation follows] Addressing unmet needs in structural heart disease, vascular therapy and urology. Affluent Medical is a new French medtech player with the ambition of becoming one of the European leaders in the cardiovascular and urological fields. Affluent Medical is developing innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and the risk of recurrence of abdominal aortic aneurysms, allowing patients to live more peacefully in the face of an unpredictable risk of rupture; - Kalios and Epygon aim to offer more physiological surgical treatments for the repair or … Type: | 3 | 2 | 1 | 68 |
 | Agatha Inc. We help life sciences companies manage clinical, quality, and regulatory processes so they can focus on improving lives With offices in the US, Europe, Japan and Japan, Agatha is dedicated to helping the world’s Hospitals, biotechnology, pharmaceutical, contract research organizations and medical device firms optimize the management of their Quality, Regulatory and Clinical documentation and processes. With lower costs and faster on-boarding, Agatha delivers the best ROI on business applications for life sciences that are ready to use and easy to adopt. Agatha, Inc. is a strategic software solution provider to the healthcare and life sciences industry, providing SaaS-based business … Type: | 1 | 0 | 1 | 44 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 5 |
 | Agenus Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing Type: | 1 | 0 | 1 | 297 |
 | AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: | 0 | 0 | 0 | 12 |
 | AgGene Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology Type: | 2 | 2 | 0 | 5 |
 | Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: | 2 | 1 | 1 | 505 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: | 0 | 0 | 0 | 49 |
 | Agro-Bio Antibodies Our specificity, your antibodies Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects. Our services around antibody: • Bioanalysis/Biopharma: o Anti-idiotypic antibodies for positive control, PK and potency test, o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit, o Epitope … Type: | 0 | 0 | 0 | 48 |
 | AGTC Visionary science for life-changing cures. AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 … Type: | 1 | 1 | 1 | 118 |
 | Aguettant France [Automatic translation follows] Essential for life Welcome to the AGUETTANT France LinkedIn page! AGUETTANT is a French family pharmaceutical laboratory, dedicated to the development, manufacturing and marketing of injectable pharmaceutical specialties used or initiated in hospitals. AGUETTANT puts its expertise at the service of progress and medical innovation to design the therapeutic solutions of tomorrow. Find all the news from AGUETTANT France on this page. Anesthesia - Resuscitation, Parenteral Nutrition, Emergency Injectables, Parkinson's Disease, and Spasticity Type: | 3 | 1 | 1 | 42 |
 | AGV Discovery [Automatic translation follows] AGV Discovery offers services in chemistry, cell biology, in vitro screening, rational drug design, outsourcing and consultancy. AGV Discovery is a pharmaceutical company that specializes in the rational design and early development of drug candidates. Type: | 0 | 0 | 0 | 4 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … Type: | 1 | 0 | 1 | 18 |
 | Aidplex MedTech Startup providing innovative solutions in orthopedics Aidplex is an orthopedics company whose patient-centric products are revolutionizing the treatment and monitoring of orthopedic patients. Starting with Scoliosis treatment, Aidplex launched ScolioSense. ScolioSense is a patent-pending medical device designed to ensure the quality of scoliosis treatment by combining portability, accuracy, and assurance of the correct fitting of the back brace. Orthopedics, HealthTech, Patient-Centric solutions, Rehabilitation, scoliosis, medical devices, and quality assurance Type: | 1 | 1 | 0 | 7 |
 | AIG Hospitals India's most advanced Multi Speciality Hospital with Superlative Care AIG Hospitals, Hyderabad AIG Hospitals is a unit of Asian Institute of Gastroenterology, India’s foremost Gastroenterology hospital. It is a state-of-the-art super specialty Hospital and is a world-leader to undertake Transplant surgeries including Liver, Kidney, Heart, Pancreas and Islet Cell. We believe in creating a positive and nurturing environment that is conducive to healing. Cardiology , Gastroenterology, Hepatology, Oncology, Neurology & Neurosurgery , Pulmonology, Andrology, Orthopedics, Multi-Organ Transplants, Nephrology, and Urology Type: | 0 | 0 | 0 | 1,442 |
 | Aimmune Therapeutics POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to … Type: | 1 | 1 | 0 | 152 |
 | AIOVA [Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines, with high added value, to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | Air Liquide Medical Systems Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques Type: | 6 | 3 | 3 | 382 |
 | Airnov Healthcare Packaging Protecting Today, Preserving Tomorrow Protecting Today, Preserving Tomorrow. Type: | 0 | 0 | 0 | 163 |
 | Air-Tite Products Co., Inc. Syringe and Needle Specialists serving the Human Health, Laboratory, Aesthetics, & Veterinary Communities since 1926 Air-Tite Products is a company of syringe and needle experts, specializing in hypodermics since 1926. We focus on providing personalized service to our customers and distinguish ourselves with hard-to-find niche products. Air-Tite Products is a direct importer of high-quality products from global leaders in more than 10 different countries. Whether you need an off-the-shelf solution from our hundreds of stocked products, or to leverage the capabilities of our manufacturing partners for a custom solution, Air-Tite can identify options that best meet your individual application’s requirements. … Type: | 3 | 0 | 3 | 20 |
 | AIS BIOTECH Fight against emerging infectious diseases @AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the @Région Auvergne-Rhône-Alpes, France, incorporated in March 2023 with the objective of developing a new class of sugar-based anti-infective biotherapeutics to fight (re)emerging infectious diseases. Thanks to a Bioengineering plateform based on the expertise of the leading edge academic laboratory @CERMAV (@CNRS, @UGA, Grenoble, France), AIS Biotech aims to develop a pipeline of innovative sugar-based biopharmaceuticals which can prevent or treat infections by mimicking the natural host surface oligosaccharide binding-sites of pathogens. GlycoFlu, our first drug-candidate validated at the preclinical … Type: | 15 | 4 | 13 | 5 |
 | AJA Pharma [Automatic translation follows] Aja Pharmaceutical Industries Company was established as one of the Saudi chemical companies, and it is the company known internationally as a leading Saudi joint stock company since its founding in 1972 AD. Aga Pharma owns a factory that is considered a distinctive technological mark among pharmaceutical factories, with its huge capabilities in accordance with the latest internationally known technologies in the field of the pharmaceutical industry. The factory is located in the industrial city of Hail in the north of the Kingdom of Saudi Arabia, and aspires to provide the highest and latest levels of quality … Type: | 1 | 1 | 0 | 282 |
 | Ajinomoto Bio-Pharma Services The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet … Type: | 0 | 0 | 0 | 775 |
SMB